Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Invitae Corp NVTAQ

Invitae Corporation is a medical genetics company. The Company is engaged in delivering genetic testing services, digital health solutions, and health data services that support a lifetime of patient care and improved outcomes. It offers genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. It applies... see more

Recent & Breaking News (GREY:NVTAQ)

SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - NGHC, DCOM, NVTA

ACCESSWIRE IA July 16, 2020

INVESTIGATION ALERT: Halper Sadeh LLP is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - GARS, NVTA, REXN

ACCESSWIRE IA July 14, 2020

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Invitae Corporation (NYSE - NVTA)

ACCESSWIRE IA July 9, 2020

ALERT: Halper Sadeh LLP Continues to Investigate Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - NGHC, NVTA, GRUB

ACCESSWIRE IA July 8, 2020

Moore Kuehn Encourages DCOM, MYOS, ADSW, and NVTA Investors to Contact Law Firm

PR Newswire July 8, 2020

SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - NVTA, MYOS, DCOM

ACCESSWIRE IA July 7, 2020

LEGAL INVESTIGATION ALERT: Halper Sadeh LLP Announces It is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - ADSW, GARS, NVTA

ACCESSWIRE IA July 3, 2020

INVITAE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Invitae Corporation - NVTA

Business Wire July 1, 2020

Invitae Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Merger Of Invitae Corporation Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm

PR Newswire June 26, 2020

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Invitae Corporation with ArcherDX is Fair to NVTA Shareholders

Newsfile June 24, 2020

Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology

PR Newswire June 22, 2020

Recent Research And New Multidisciplinary Framework For Genetic Testing In Prostate Cancer Supports Broader Use Of Panels, Testing In Early Stage Disease

PR Newswire June 11, 2020

Invitae to Present at the William Blair 40th Annual Growth Stock Conference

PR Newswire May 28, 2020

Invitae makes it easier for consumers to access medical genetic tests in Canada

Canada NewsWire May 7, 2020

Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020

PR Newswire May 5, 2020

Invitae to announce first quarter 2020 financial results on May 5, 2020

PR Newswire April 21, 2020

Axovant Announces Partnership with Invitae to Increase Access to Genetic Testing and Accelerate Diagnoses of GM1 and GM2 Gangliosidosis

GlobeNewswire April 15, 2020

Invitae launches enhanced capabilities to support telemedicine

PR Newswire April 7, 2020

Invitae Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock and Closing of Underwritten Public Offering

PR Newswire April 6, 2020

Invitae Announces Pricing of Public Offering of Common Stock

PR Newswire April 1, 2020